Sun, Jul 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Gramercy announces Doug Krehbiel to lead new European (London) office

Tuesday, November 30, 2010
Opalesque Industry UPdate - Gramercy, a dedicated emerging markets investment manager, today announced it has opened an office in London. The firm also announced that Doug Krehbiel recently joined as Managing Director and European Regional Head. His appointment was effective in early summer and he is based in London.

In his new position, Mr. Krehbiel is responsible for leading the research and the investment management process relating to the allocation of capital to Central and Eastern Europe, Middle East and Africa (“CEEMEA”) positions and will work in concert with Gramercy’s investment management team. Mr. Krehbiel is also a member of the firm’s centralized investment committee.

Mr. Krehbiel’s 18 years of emerging markets performing and distressed debt experience will strengthen the firm’s investment, trading and client service capabilities. Mr. Krehbiel was previously at BlueCrest Capital Management where he led global emerging markets credit research.

Robert Koenigsberger, Managing Partner and Chief Investment Officer of Gramercy, said, “Doug’s senior leadership and diverse global experience will be important to Gramercy’s continued success as we expand our overall European presence and establish a true beachhead via our new London-based investment practice.” Mr. Krehbiel will source regional assets and help manage portfolios along with other members of Gramercy in both Europe and the US.

Robert Rauch, Partner and Head of Research at Gramercy, commented, “We are pleased to have Doug join Gramercy’s emerging markets team to oversee our CEEMEA investments as we see tremendous opportunities in the region. Doug’s nearly two decades of global emerging markets experience will complement the efforts of our current Eastern European team based in Bulgaria, as well as leverage the Gramercy team in all locations.”

Since 2003 Mr. Krehbiel has been based in London and his career has afforded him broad investment experience in private debt, Eurobonds and special situations throughout the emerging markets. During his 14 year tenure with JP Morgan, Mr. Krehbiel was a team leader of an Institutional Investor top ranking research team.

“Gramercy’s long-standing commitment to emerging markets and its rigorous, collegial culture, make it a unique platform from which to exploit credit opportunities,” said Mr. Krehbiel. “We will build on the firm’s successes in the CEEMEA region including performing and distressed debt as well as mezzanine finance.”

The office is located at 1 Knightsbridge Green, London SW1X 7NE and the phone number is +44-20-3330-0545.

(press release)

Source

kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

 

banner